Page last updated: 2024-10-22

albuterol and Airway Obstruction

albuterol has been researched along with Airway Obstruction in 165 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Airway Obstruction: Any hindrance to the passage of air into and out of the lungs.

Research Excerpts

ExcerptRelevanceReference
"The pentosidine levels did not significantly differ between the two asthmatic subgroups with and without airway obstruction."9.16Association of airway pentosidine levels with bronchodilator response mediated by salbutamol administration in asthmatic patients. ( Hirata, K; Kanazawa, H; Tamagaki, G, 2012)
"Aerosolised albuterol is an effective bronchodilator in horses with recurrent airway obstruction."9.15Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction. ( Bertin, FR; Couëtil, LL; Ivester, KM, 2011)
"To determine the onset, magnitude, and duration of bronchodilation after administration of aerosolized salmeterol xinafoate in horses with recurrent airway obstruction."9.09Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction. ( Henrikson, SL; Rush, BR, 2001)
"Twenty-one patients with chronic bronchitis and reversible airway obstruction participated in two single-blind, cross-over, placebo-controlled studies in inhaled clenbuterol - a new bronchodilator - and salbutamol."9.05A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. ( Baronti, A; Grieco, A; Vibelli, C, 1980)
"Indoramin, an alpha adrenoreceptor antagonist, was given in tablet form, in addition to regular salbutamol by aerosol, to 30 patients with airway obstruction."9.04Indoramin--an alpha adrenoreceptor antagonist for airway obstruction. ( Campbell, IA; Dyson, AJ, 1977)
"Evaluation of the efficacy of nebulized magnesium sulfate (MgSO4) alone and in combination with salbutamol in acute asthma."7.83The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma. ( Ali, MA; El-Garhy, OH; Sarhan, HA; Youssef, NA, 2016)
"In patients with asthma, increased airway obstruction results in greater reductions in R(0) and Edyn after albuterol use."7.75Effects of airway obstruction on albuterol-mediated variations in the resistive and elastic properties of the respiratory system of patients with asthma. ( de Melo, PL; Jansen, JM; Lopes, AJ; Veiga, J, 2009)
"Fifty children primarily with moderate-to-severe asthma were followed with measurements of urinary LTE(4), monitoring of FEV(1), and albuterol use."7.73Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. ( Gelfand, EW; Rabinovitch, N; Zhang, L, 2006)
"Inhaled acetaldehyde and adenosine 5'-monophosphate (AMP) cause bronchoconstriction in asthmatics by a mechanism believed to involve histamine release from airway mast cells."7.71Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness. ( Cervera, A; Gutiérrez, V; Liñana, J; Prieto, L, 2002)
"To determine whether pulmonary distribution of aerosolized technetium Tc 99m pentetate is improved after inhalation of a single dose of albuterol sulfate in horses susceptible to recurrent airway obstruction (heaves)."7.70Pulmonary distribution of aerosolized technetium Tc 99m pentetate after administration of a single dose of aerosolized albuterol sulfate in horses with recurrent airway obstruction. ( Davis, EG; Hakala, JE; Hoskinson, JJ; Matson, CJ; Rush, BR, 1999)
"To determine the dose of aerosolized albuterol sulfate required to cause bronchodilation in horses with recurrent airway obstruction (RAO) and duration of this effect."7.70Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction. ( Berney, C; Derksen, FJ; Hakala, JE; Matson, CJ; Olszewski, MA; Robinson, NE; Ruth, DT, 1999)
"Multiple aspects of lung function were measured in 17 cystic fibrosis (CF) patients on four occasions: without therapy (0); with oral theophylline medication (Th); after inhalation of salbutamol (beta 2); and with combined medication (Th + beta 2)."7.67Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. ( Eber, E; Oberwaldner, B; Zach, MS, 1988)
"Intravenous injections of aminophylline (250 mg) and tablets of theophylline (Neulin) (400 mg) were given, on separate occasions, to 10 patients with partially reversible severe airway obstruction."7.65Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction. ( Freitag, A, 1976)
"Both procaterol and albuterol were highly effective in improving pulmonary function and controlling symptoms of asthma; both were well tolerated."6.67Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma. ( Mazza, JA; Reed, CE; Tashkin, DP, 1992)
"Post hoc descriptive analysis of data stratified by FAO category (screening post-albuterol FEV1/FVC 5.19Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses. ( Chipps, BE; Tashkin, DP; Trudo, F; Zangrilli, JG, 2014)
"The pentosidine levels did not significantly differ between the two asthmatic subgroups with and without airway obstruction."5.16Association of airway pentosidine levels with bronchodilator response mediated by salbutamol administration in asthmatic patients. ( Hirata, K; Kanazawa, H; Tamagaki, G, 2012)
"Aerosolised albuterol is an effective bronchodilator in horses with recurrent airway obstruction."5.15Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction. ( Bertin, FR; Couëtil, LL; Ivester, KM, 2011)
"This study assessed the effect of the leukotriene receptor antagonist montelukast on hypertonic saline-induced airway obstruction."5.10Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD. ( Böhme, S; Jörres, RA; Kanniess, F; Magnussen, H; Nielsen-Gode, D; Richter, K; Zühlke, IE, 2003)
"To determine the onset, magnitude, and duration of bronchodilation after administration of aerosolized salmeterol xinafoate in horses with recurrent airway obstruction."5.09Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction. ( Henrikson, SL; Rush, BR, 2001)
"The efficacy and safety of orally administered procaterol hydrochloride, a potent beta 2-adrenergic bronchodilator, was compared with that of albuterol in an eight-center, double-blind study conducted in 223 patients with mild to moderate, reversible bronchial airway obstruction."5.06A comparison of oral procaterol and albuterol in reversible airflow obstruction. ( Beaupre, A; Boulet, LP; Brandon, ML; Busse, WW; Chervinsky, P; Mazza, J; Petty, TL; Schoenweter, W, 1988)
"Metaproterenol (15 mg) and albuterol (5 mg) solutions were each nebulized and delivered to 20 patients with reversible airway obstruction utilizing intermittent positive pressure ventilation in a double-blind comparison."5.06A comparison of albuterol and metaproterenol nebulizer solutions. ( Campbell, SC; Habib, MP; Pinnas, JL; Shon, BY, 1987)
"Twenty-one patients with chronic bronchitis and reversible airway obstruction participated in two single-blind, cross-over, placebo-controlled studies in inhaled clenbuterol - a new bronchodilator - and salbutamol."5.05A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. ( Baronti, A; Grieco, A; Vibelli, C, 1980)
"Indoramin, an alpha adrenoreceptor antagonist, was given in tablet form, in addition to regular salbutamol by aerosol, to 30 patients with airway obstruction."5.04Indoramin--an alpha adrenoreceptor antagonist for airway obstruction. ( Campbell, IA; Dyson, AJ, 1977)
"The indications for heliox during mechanical ventilation are lower-airway obstruction, especially with hypercarbia; need to enhance aerosol delivery to lung periphery; and need to facilitate weaning from mechanical ventilation."4.83Heliox during mechanical ventilation. ( Venkataraman, ST, 2006)
"Evaluation of the efficacy of nebulized magnesium sulfate (MgSO4) alone and in combination with salbutamol in acute asthma."3.83The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma. ( Ali, MA; El-Garhy, OH; Sarhan, HA; Youssef, NA, 2016)
"In patients with asthma, increased airway obstruction results in greater reductions in R(0) and Edyn after albuterol use."3.75Effects of airway obstruction on albuterol-mediated variations in the resistive and elastic properties of the respiratory system of patients with asthma. ( de Melo, PL; Jansen, JM; Lopes, AJ; Veiga, J, 2009)
"Fifty children primarily with moderate-to-severe asthma were followed with measurements of urinary LTE(4), monitoring of FEV(1), and albuterol use."3.73Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. ( Gelfand, EW; Rabinovitch, N; Zhang, L, 2006)
"Inhaled acetaldehyde and adenosine 5'-monophosphate (AMP) cause bronchoconstriction in asthmatics by a mechanism believed to involve histamine release from airway mast cells."3.71Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness. ( Cervera, A; Gutiérrez, V; Liñana, J; Prieto, L, 2002)
"To determine whether pulmonary distribution of aerosolized technetium Tc 99m pentetate is improved after inhalation of a single dose of albuterol sulfate in horses susceptible to recurrent airway obstruction (heaves)."3.70Pulmonary distribution of aerosolized technetium Tc 99m pentetate after administration of a single dose of aerosolized albuterol sulfate in horses with recurrent airway obstruction. ( Davis, EG; Hakala, JE; Hoskinson, JJ; Matson, CJ; Rush, BR, 1999)
"To determine the dose of aerosolized albuterol sulfate required to cause bronchodilation in horses with recurrent airway obstruction (RAO) and duration of this effect."3.70Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction. ( Berney, C; Derksen, FJ; Hakala, JE; Matson, CJ; Olszewski, MA; Robinson, NE; Ruth, DT, 1999)
" Bronchial challenge tests were carried out with cumulative doses of inhaled carbachol in 10 healthy children (aged 7-14 yrs) and 50 asthmatic children (aged 5-15 yrs)."3.69Oscillatory pressure transients after flow interruption during bronchial challenge test in children. ( Frey, U; Kraemer, R, 1997)
"We compared mood variables, symptom severity, albuterol use, and peak expiratory flow rate (PEFR) measured three times daily over a 21-day period in 21 adults with moderate to severe asthma."3.69Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood. ( Affleck, G; Apter, AJ; Barrows, E; Reisine, ST; Tennen, HA; Wells, M; Willard, A; ZuWallack, RL, 1997)
"In guinea pigs passively sensitized to ovalbumin, sustained (6 days) subcutaneous infusion of (+/-)salbutamol (1 mg/kg/day) induced significant airway obstruction and heightened responsivity to airway spasmogens."3.68Exacerbation of airway hyperreactivity by (+/-)salbutamol in sensitized guinea pig. ( Hoshiko, K; Morley, J, 1993)
" We conclude that smooth muscle contraction is important in A23187-induced airway obstruction; 5-hydroxytryptamine, thromboxane A2 and lipoxygenase products may be involved in maintaining this response; and that this approach is useful for investigating reversal of ongoing airway constriction."3.67Reversal of A23187-induced airway constriction in the guinea pig. ( Silbaugh, SA; Stengel, PW, 1989)
" Inhalation of ovalbumin by sensitized guinea pigs induced three phases of airways obstruction: an early asthmatic response (EAR) peaking at 2 h, a late response (LAR) peaking at 17 h, and a further late response (LLAR) being observed at 72 h."3.67The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs. ( Church, MK; Holgate, ST; Hutson, PA, 1988)
"Multiple aspects of lung function were measured in 17 cystic fibrosis (CF) patients on four occasions: without therapy (0); with oral theophylline medication (Th); after inhalation of salbutamol (beta 2); and with combined medication (Th + beta 2)."3.67Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics. ( Eber, E; Oberwaldner, B; Zach, MS, 1988)
"Intravenous injections of aminophylline (250 mg) and tablets of theophylline (Neulin) (400 mg) were given, on separate occasions, to 10 patients with partially reversible severe airway obstruction."3.65Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction. ( Freitag, A, 1976)
"Asthma and chronic obstructive pulmonary disease (COPD) are heterogeneous disorders encompassing different phenotypes of airflow obstruction, which might differ in their response to treatment."2.80Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. ( Beasley, R; Bowles, D; Charles, T; Fingleton, J; Shirtcliffe, P; Strik, R; Travers, J; Weatherall, M; Williams, M, 2015)
"Data on the onset of action of COPD medications are lacking."2.73Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. ( Lindberg, A; Pullerits, T; Radeczky, E; Szalai, Z, 2007)
" Dose-response curves were compared using an analysis of covariance."2.69Tolerance to beta-agonists during acute bronchoconstriction. ( Aldridge, RE; Cowan, JO; Flannery, EM; Hancox, RJ; Herbison, GP; McLachlan, CR; Taylor, DR; Town, GI, 1999)
" When parallel and linear cumulative dose-response curves were statistically compared on a logarithmic scale, the dose potency of salbutamol Turbuhaler vs salbutamol Diskhaler was 1."2.69Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction. ( Arweström, E; Carlsson, LG; Friberg, K; Källén, A; Löfdahl, CG; Lunde, H, 1998)
" Salmeterol was well tolerated as assessed by pulse, blood pressure, haematological and biochemical variables and number of adverse events."2.68The efficacy and safety of inhaled salmeterol 50 microg bd in older patients with reversible airflow obstruction. ( Luce, P; Starke, ID, 1996)
"Finally, baseline airway obstruction correlated with the degree of bronchodilation achieved with MK-571 (r = -0."2.67Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. ( Bush, RK; Busse, WW; Gaddy, JN; Margolskee, DJ; Williams, VC, 1992)
" After each period, dose-response curves were measured on 4 study days with doubling doses of salbutamol, ipratropium, a combination of salbutamol and ipratropium, and placebo until a plateau in FEV1 was reached."2.67Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma. ( Alting-Hebing, D; Breederveld, N; Koëter, GH; Postma, DS; van der Mark, TW; Wempe, JB, 1992)
"Both procaterol and albuterol were highly effective in improving pulmonary function and controlling symptoms of asthma; both were well tolerated."2.67Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma. ( Mazza, JA; Reed, CE; Tashkin, DP, 1992)
" To determine whether these drugs also protect against excessive airway narrowing, the effect of inhaled salbutamol on the position and shape of the dose-response curves for histamine or methacholine was investigated in 12 patients with asthma and 11 with chronic obstructive lung disease."2.67The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. ( Bel, EH; Dijkman, JH; Sterk, PJ; Timmers, MC; Zwinderman, AH, 1991)
"A double-blind, randomized crossover trial was carried out in 10 patients with reversible airways obstruction to assess dose-response and duration of action of 0."2.66A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action. ( McIntosh, D, 1986)
" Increase of dosage did not lead to improved effectiveness."2.65[Parasympathicolytic drugs in treatment of obstructive lung diseases (author's transl)]. ( Gonsior, E; Meier-Sydow, J; Schultze-Werninghaus, G, 1979)
"Tremor was recorded with the higher doses of albuterol."2.64Albuterol and ephedrine in patients with reversible obstructive airway disease. ( Whitsett, TL, 1977)
"Rimiterol is an acceptable alternative to the short-acting isoprenaline but lacks the cardiovascular effects of isoprenaline and is an alternative to salbutamol where very prolonged action is unnecessary."2.64Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol. ( Bianco, S; Kamburoff, PL; Prime, FJ, 1975)
"Status asthmaticus is a frequent cause of admission to a pediatric intensive care unit."2.49Pediatric status asthmaticus. ( Carroll, CL; Sala, KA, 2013)
"The sensitivity of detecting airway obstruction in these children by FEV1 was 15."1.43Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma. ( Bar-Yoseph, R; Bentur, L; Hakim, F; Livnat, G; Ofek, M; Vilozni, D, 2016)
"Airway obstruction was more severe in COPD patients as compared with controls (mean FEV1 and FEV1% predicted both P<0."1.43Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. ( Gálffy, G; Kováts, Z; Müller, V; Odler, B; Orosz, M; Selroos, O; Tamási, L, 2016)
"We evaluated 21 patients with airway obstruction at the Department of Pulmonary Medicine, Samsun Medicalpark Hospital, Samsun, Turkey."1.40The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstruction. ( Bayrak, MG; Bostancı, O; Dirican, A; Ece, F; Karanfil, RC; Kaya, SO; Ozkaya, S, 2014)
"COPD was likely the predominant diagnosis but patients with asthma may have been included."1.36Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. ( Deesomchok, A; Forkert, L; Jensen, D; Lam, YM; O'Donnell, DE; Ofir, D; Webb, KA, 2010)
"Airway emergencies were the most common emergencies seen in the offices."1.33Preparedness of selected pediatric offices to respond to critical emergencies in children. ( Gausche-Hill, M; Santillanes, G; Sosa, B, 2006)
" Bronchial lability was characterized by (1) variability in mean daily peak expiratory flow rate and (2) bronchial responsiveness to either carbachol (as assessed by the threshold dose and the slope of the dose-response curve) or salbutamol (as assessed by the threshold dose and maximal response)."1.28Relationship between spontaneous dyspnoea and lability of airway obstruction in asthma. ( Lockhart, A; Marsac, J; Peiffer, C; Razzouk, H; Toumi, M, 1992)

Research

Studies (165)

TimeframeStudies, this research(%)All Research%
pre-199072 (43.64)18.7374
1990's41 (24.85)18.2507
2000's29 (17.58)29.6817
2010's23 (13.94)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gelb, AF1
Yamamoto, A1
Verbeken, EK1
Schein, MJ1
Moridzadeh, R1
Tran, D1
Fraser, C1
Barbers, R1
Elatre, W1
Koss, MN1
Glassy, EF1
Nadel, JA1
Rahmel, T1
Koniusch, A1
Schwertner, M1
Oprea, G1
Adamzik, M1
Nowak, H1
Johnson, J1
Johnson, SR1
Carroll, CL1
Sala, KA1
Yang, J1
Stanton, J1
Wang, L1
Beckert, L1
Frampton, C1
Burton, D1
Swanney, MP1
Tashkin, DP2
Chipps, BE1
Trudo, F1
Zangrilli, JG1
Ioan, I2
Coutier, L2
Bonabel, C2
Demoulin, B2
Marchal, F3
Schweitzer, C3
Varechova, S2
Maneechotesuwan, K1
Assawabhumi, J1
Rattanasaengloet, K1
Suthamsmai, T1
Pipopsuthipaiboon, S1
Udompunturak, S1
Ozkaya, S1
Dirican, A1
Kaya, SO1
Karanfil, RC1
Bayrak, MG1
Bostancı, O1
Ece, F1
Albrecht, J1
Fingleton, J1
Travers, J1
Williams, M1
Charles, T1
Bowles, D1
Strik, R1
Shirtcliffe, P1
Weatherall, M1
Beasley, R1
Hansen, M1
Meckler, G1
Lambert, W1
Dickinson, C1
Dickinson, K1
Guise, JM1
Müller, V1
Gálffy, G1
Orosz, M1
Kováts, Z1
Odler, B1
Selroos, O1
Tamási, L1
Neininger, MP1
Bertsche, T1
Sarhan, HA1
El-Garhy, OH1
Ali, MA1
Youssef, NA1
Vilozni, D1
Hakim, F1
Livnat, G1
Ofek, M1
Bar-Yoseph, R1
Bentur, L1
Sterner, JB1
Zanders, TB1
Morris, MJ1
Cancio, LC1
Angulo, M1
Taranto, E1
Soto, JP1
Malacrida, L1
Nin, N1
Hurtado, FJ1
Píriz, H1
Borrill, Z1
Roy, K1
Kolsum, U1
Southworth, T1
Vestbo, J2
Singh, D1
Veiga, J1
Lopes, AJ1
Jansen, JM1
de Melo, PL1
van Noord, JA1
Aumann, JL1
Janssens, E1
Smeets, JJ1
Zaagsma, J1
Mueller, A1
Cornelissen, PJ1
Deesomchok, A1
Webb, KA1
Forkert, L1
Lam, YM1
Ofir, D1
Jensen, D1
O'Donnell, DE1
Bertin, FR1
Ivester, KM1
Couëtil, LL1
Miranda, AD1
Valdez, TA1
Pereira, KD1
Dahlén, B1
Gómez, FP1
Casas, A1
Howarth, PH1
Dahlén, SE1
Rodriguez-Roisin, R1
Mackenzie, SD1
Blois, S1
Hayes, G1
Vince, AR1
Tamagaki, G1
Kanazawa, H1
Hirata, K1
Moreau-Colson, C1
Prieto, L1
Gutiérrez, V1
Cervera, A1
Liñana, J1
Saldien, V1
Coppejans, HC1
Vercauteren, MP1
Corthouts, B1
Van de Heyning, P1
Jorens, PG1
Silvestri, M1
Sabatini, F1
Sale, R1
Defilippi, AC1
Fregonese, L1
Battistini, E1
Biraghi, MG1
Rossi, GA1
Lindqvist, A1
Karjalainen, EM1
Laitinen, LA1
Kava, T1
Altraja, A1
Pulkkinen, M1
Halme, M1
Laitinen, A1
Cazzola, M1
Matera, MG1
Zühlke, IE1
Kanniess, F1
Richter, K1
Nielsen-Gode, D1
Böhme, S1
Jörres, RA1
Magnussen, H1
Robin, B1
Kim, YJ1
Huth, J1
Klocksieben, J1
Torres, M1
Tepper, RS1
Castile, RG1
Solway, J1
Hershenson, MB1
Goldstein-Filbrun, A1
Tomari, S1
Matsuse, H1
Machida, I1
Kondo, Y1
Kawano, T1
Obase, Y1
Fukushima, C1
Shimoda, T1
Kohno, S1
Silvanus, MT1
Groeben, H1
Peters, J1
Lødrup Carlsen, KC1
Pettersen, M1
Carlsen, KH1
Ezzahir, N1
Leske, V1
Peiffer, C2
Trang, H1
Bussamra, MH1
Cukier, A1
Stelmach, R1
Rodrigues, JC1
Tamura, G1
Suda, Y1
Thomas, MR1
Rafferty, GF1
Blowes, R1
Peacock, JL1
Marlow, N1
Calvert, S1
Milner, A1
Greenough, A1
Venkataraman, ST1
Zagdańska, R1
Grzelewska-Rzymowska, I1
Rabinovitch, N1
Zhang, L1
Gelfand, EW1
Santillanes, G1
Gausche-Hill, M1
Sosa, B1
Lindberg, A1
Szalai, Z1
Pullerits, T1
Radeczky, E1
Dyson, AJ2
Mackay, AD1
Packe, GE1
Cayton, RM1
Mashhoudi, N1
Kaik, G1
Kaik, B1
Laggner, A1
Firstater, E1
Mizrachi, E1
Topilsky, M1
Giulekas, D1
Tsakalos, N1
Christaki-Kukuriku, P1
Kotsopoulos, T1
Antoniou, D1
Carmichael, J1
Paterson, IC1
Diaz, P1
Crompton, GK2
Kay, AB1
Grant, IW1
Hughes, D1
Mindorff, C1
Levison, H1
Dalén, G1
Kjellman, B1
Emslander, HP1
Baronti, A1
Grieco, A1
Vibelli, C1
Surovov, IuA1
Sil'vestrov, VP1
Pakulin, IA1
Sahay, JN1
Chatterjee, SS1
Ormerod, LP1
Thomson, RA1
Anderson, CM1
Stableforth, DE1
Congleton, J1
Muers, MF1
Malo, JL1
L'Archevêque, J1
Ghezzo, H1
Cartier, A1
Fergusson, RJ1
Stewart, CM1
Wathen, CG1
Moffat, R1
Verberne, AA1
Hop, WC1
Bos, AB1
Kerrebijn, KF2
Hoshiko, K1
Morley, J1
Lundback, B1
Rawlinson, DW1
Palmer, JB1
Clough, JB1
Starke, ID1
Luce, P1
Malerba, M1
Boni, E1
Tantucci, C1
Filippi, B1
Romagnoni, G1
Grassi, V1
Frey, U2
Schibler, A1
Kraemer, R2
Emerman, CL1
Cydulka, RK1
Apter, AJ1
Affleck, G1
Reisine, ST1
Tennen, HA1
Barrows, E1
Wells, M1
Willard, A1
ZuWallack, RL1
Weersink, EJ1
van Zomeren, EH1
Koëter, GH2
Postma, DS2
Lin, RY1
Pesola, GR1
Westfal, RE1
Bakalchuk, L1
Freyberg, CW1
Cataquet, D1
Heyl, GT1
Ragg, MD1
Nour, MM1
Mustafa, KY1
Mousa, K1
Abul, AT1
Shuhaibar, H1
Yousif, AM1
Carlsson, LG1
Arweström, E1
Friberg, K1
Källén, A1
Lunde, H1
Löfdahl, CG2
Moy, ML1
Lantin, ML1
Harver, A1
Schwartzstein, RM1
Pellegrino, R1
Rodarte, JR1
Brusasco, V1
Mellén, A1
Arvidsson, P1
Palmqvist, M1
Lötvall, J1
Brand, PL1
Duiverman, EJ1
Waalkens, HJ1
van Essen-Zandvliet, EE1
Derksen, FJ1
Olszewski, MA1
Robinson, NE1
Berney, C1
Hakala, JE2
Matson, CJ2
Ruth, DT1
Rush, BR2
Hoskinson, JJ1
Davis, EG1
Walton, JS1
Fears, R1
Burt, N1
Dorman, BH1
Hancox, RJ1
Aldridge, RE1
Cowan, JO1
Flannery, EM1
Herbison, GP1
McLachlan, CR1
Town, GI1
Taylor, DR1
Fink, J1
Dhand, R1
Manthous, CA1
Lee, T1
Dennis, S1
Ziebach, R1
Pietsch-Breitfeld, B1
Bichler, M1
Busch, A1
Riethmüller, J1
Stern, M1
Henrikson, SL1
Marlin, GE3
Hartnett, BJ1
Berend, N2
Schultze-Werninghaus, G1
Gonsior, E1
Meier-Sydow, J1
Madsen, BW1
Tandon, MK1
Paterson, JW1
Patel, KR1
Kerr, JW2
Anderson, SD1
Silverman, M1
König, P2
Godfrey, S3
Gayrard, P1
Orehek, J1
Charpin, J1
Sly, RM1
Schindl, R1
Kamburoff, PL2
Prime, FJ3
Schmidt, OP1
Campbell, IA3
Whitsett, TL1
Simonsson, BG1
Arvidsson, I1
Haldeborg, M1
Månsson, A1
Webster, J1
Pierce, RJ1
Allen, CJ1
Campbell, AH1
Maneksha, S2
Knoop, U1
Nogrady, SG1
Evans, WV1
Davies, BH2
Baur, X1
Fruhmann, G1
Lidington, RE1
Cotton, DJ1
Graham, BL1
Dosman, JA1
Dash, CH3
McHardy, GJ2
Shotter, MV2
Cockcroft, DW1
Donevan, RE1
Copland, GM1
Perko, V1
Falaschi, C1
Rubin, AH1
Mansur, A1
Schey, G1
Shahor, Y1
Bruderman, I1
Freitag, A1
Spiro, SG1
Minette, A1
Petrie, GR1
Palmer, KN2
Bianco, S1
Radcliffe, S1
Seaton, A1
Graham, JD1
Toumi, M1
Razzouk, H1
Marsac, J1
Lockhart, A1
Flurkey, HG1
Gromova, OA1
Gusel', VA1
Waterhouse, JC1
Simmons, JL1
Wray, H1
Howard, P1
Gaddy, JN1
Margolskee, DJ1
Bush, RK1
Williams, VC1
Busse, WW2
Wempe, JB1
Breederveld, N1
Alting-Hebing, D1
van der Mark, TW1
Mazza, JA1
Reed, CE1
Derom, EY1
Pauwels, RA1
Weir, DC1
Sherwood Burge, P1
Dirksen, A1
Christensen, H1
Evald, T1
Jensen, BV1
Jensen, JI1
Keittelmann, S1
Kok-Jensen, A1
Bel, EH1
Zwinderman, AH1
Timmers, MC1
Dijkman, JH1
Sterk, PJ1
Tokuyama, K1
Lötvall, JO1
Barnes, PJ1
Chung, KF1
Hussein, A1
Harrie, K1
Kussau, D1
Riedler, J1
Vestri, R1
Philip-Joet, F1
Reynaud-Gaubert, M1
Arnaud, A1
Stengel, PW1
Silbaugh, SA1
Jenkins, C1
Breslin, AB1
Jorde, W1
Schata, M1
McIntosh, D1
Petty, TL1
Brandon, ML1
Chervinsky, P1
Schoenweter, W1
Beaupre, A1
Boulet, LP1
Mazza, J1
Deenstra, M1
Zanen, P1
Gusdorf, CF1
Hutson, PA1
Holgate, ST1
Church, MK1
Habib, MP1
Campbell, SC1
Shon, BY1
Pinnas, JL1
Eber, E1
Oberwaldner, B1
Zach, MS1
Couriel, JM1
Demis, T1
Olinsky, A1
Beardsmore, CS1
Maayan, C1
Bar-Yishay, E1
Gugger, M1
Crivelli, AM1
Galeazzi, RL1
Bachofen, H1
Noah, MS1
Kabiraj, MM1
Abdullah, AK1
Zaman, AU1
Skinner, C1
Cornia, G1
Gramiccioni, E1
Mannino, F1
McLeod, J1
Selman, J1
Dirksen, H1
Bülow, K1
Arborelius, M1
Lilja, B1
Epstein, SW2
Barnard, JA1
Zsotér, TT2
Poppius, H2
Salorinne, Y1
Cochrane, GM1
Clark, TJ1
Hanan, ME1
Harris, L1
Phelan, PD1
Stocks, JG1
Leinonen, L1
Muittari, A1
Lal, S1
Gribben, MD1

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap[NCT03263130]60 participants (Anticipated)Observational [Patient Registry]2017-01-01Recruiting
Evaluation of Mechanism(s)Limiting Expiratory Airflow in Chronic, Stable Asthmatics Who Are Non-smokers[NCT01225913]Phase 450 participants (Anticipated)Interventional2007-10-31Recruiting
Evaluation of Mechanism(s)Limiting Expiratory Airflow in Chronic, Stable Asthmatics Who Are Non-smokers[NCT00576069]60 participants (Anticipated)Observational2007-10-25Recruiting
A 12 Week, Randomized, Double-blind, Double-dummy, Placebo-controlled Trial of Symbicort TM (160/4.5mcg) Versus Its Mono-products (Budesonide and Formoterol) in Adolescents (at Least 12 Years of Age) and Adults With Asthma - SPRUCE 160/4.5[NCT00652002]Phase 3450 participants (Anticipated)Interventional2002-07-31Completed
Comparison of Doses of Nebulized Magnesium Sulphate as an Adjuvant Treatment With Salbutamol in Children With Status Asthmaticus[NCT04929626]Phase 1126 participants (Actual)Interventional2022-01-01Completed
Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients[NCT03611699]Phase 415 participants (Actual)Interventional2019-01-24Completed
Is the Exhaled Nitric Oxide in Infants a Predictive Marker of Asthma?[NCT01239199]86 participants (Actual)Interventional2010-01-31Completed
Acute Bronchodilator Responsiveness in Obliterative Bronchiolitis (OB) Following Hematopoietic Stem Cell Transplantation[NCT01112241]Phase 417 participants (Actual)Interventional2010-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Absolute Change of Forced Expiratory Volume in 1 Second (FEV1) After Bronchodilators

Following albuterol plus tiotropium inhalation, FEV1 increments ≥0.20 liters (L) as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to the American Thoracic Society-European Respiratory Society standard criteria [Pellegrino et al. Eur Respir J 2005; 26: 948-968]. They were calculated as follows: [FEV1 (L) after bronchodilators - FEV1 (L) before bronchodilators]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionabsolute positive change (liters) (Mean)
Responsives to bronchodilators (n=4)Unresponsives to bronchodilators (n=13)
Albuterol Plus Tiotropium0.260.12

Absolute Change of Forced Vital Capacity (FVC) After Bronchodilators

Following albuterol plus tiotropium inhalation, FVC increments ≥0.20 liters (L) compared with baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to the American Thoracic Society-European Respiratory Society standard criteria [Pellegrino et al. Eur Respir J 2005; 26: 948-968]. They were calculated as follows: [FVC (L) after bronchodilators - FVC (L) before bronchodilators]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionabsolute positive change (liters) (Mean)
Responsives to bronchodilators (n=5)Unresponsives to bronchodilators (n=12)
Albuterol Plus Tiotropium0.650.07

Absolute Change of Functional Residual Capacity (FRC) After Bronchodilators

Following albuterol plus tiotropium inhalation, FRC decrements ≥0.30 liters (L) as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to O'Donnell et al. [Eur Respir J 2001; 18: 914-920]. They were calculated as follows: [FRC (L), before bronchodilators - FRC (L) after bronchodilators]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionabsolute negative change (liters) (Mean)
Responsives to bronchodilators (n=4)Unresponsives to bronchodilators (n=13)
Albuterol Plus Tiotropium0.780.07

Absolute Change of Residual Volume (RV) After Bronchodilators

Following albuterol plus tiotropium inhalation, RV decrements ≥0.30 liters (L) as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to O'Donnell et al. [Eur Respir J 2001; 18: 914-920]. They were calculated as follows: [RV (L), before bronchodilators - RV (L) after bronchodilators]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionabsolute negative change (liters) (Mean)
Responsives to bronchodilators (n=8)Unresponsives to bronchodilators (n=9)
Albuterol Plus Tiotropium0.650.00

Per Cent Change of Forced Expiratory Volume in 1 Second (FEV1) After Bronchodilators

Following albuterol plus tiotropium inhalation, FEV1 increments ≥12 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to the American Thoracic Society-European Respiratory Society standard criteria [Pellegrino et al. Eur Respir J 2005; 26: 948-968]. They were calculated as follows: [FEV1, expressed in liters (L), after bronchodilators - FEV1 (L) before bronchodilators/FEV1 (L) before bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionper cent positive change (Mean)
Responsives to bronchodilators (n=4)Unresponsives to bronchodilators (n=13)
Albuterol Plus Tiotropium147

Per Cent Change of Forced Vital Capacity (FVC) After Bronchodilators

Following albuterol plus tiotropium inhalation, FVC increments ≥12 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to the American Thoracic Society-European Respiratory Society standard criteria [Pellegrino et al. Eur Respir J 2005; 26: 948-968]. They were calculated as follows: [FVC, expressed in liters (L), after bronchodilators - FVC (L) before bronchodilators/FVC (L) before bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionper cent positive change (Mean)
Responsives to bronchodilators (n=5)Unresponsives to bronchodilators (n=12)
Albuterol Plus Tiotropium242

Per Cent Change of Functional Residual Capacity (FRC) After Bronchodilators

Following albuterol plus tiotropium inhalation, FRC decrements ≥10 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to O'Donnell et al. [Eur Respir J 2001; 18: 914-920]. They were calculated as follows: [FRC, expressed in liters (L), before bronchodilators - FRC (L) after bronchodilators/FRC (L) after bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionper cent negative change (Mean)
Responsives to bronchodilators (n=4)Unresponsives to bronchodilators (n=13)
Albuterol Plus Tiotropium162

Per Cent Change of Instantaneous Maximal Forced Expiratory Flow (V'Max) After Bronchodilators

Following albuterol plus tiotropium inhalation, V'max increments ≥40 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to Pellegrino et al. [Chest 1998; 114:1607-1612]. They were calculated as follows: [V'max, expressed in liters.second-1 (L.s-1), after bronchodilators - V'max (L.s-1) before bronchodilators/V'max (L.s-1) before bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionper cent positive change (Mean)
Responsives to bronchodilators (n=4)Unresponsives to bronchodilators (n=13)
Albuterol Plus Tiotropium6614

Per Cent Change of Partial Forced Expiratory Flow (V'Part) After Bronchodilators

Following albuterol plus tiotropium inhalation, V'part increments ≥40 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to Pellegrino et al. [Chest 1998; 114:1607-1612]. They were calculated as follows: [V'part, expressed in liters.second-1 (L.s-1), after bronchodilators - V'part (L.s-1) before bronchodilators/V'part (L.s-1) before bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionper cent positive change (Mean)
Responsives to bronchodilators (n=9)Unresponsives to bronchodilators (n=8)
Albuterol Plus Tiotropium5917

Per Cent Change of Residual Volume (RV) After Bronchodilators

Following albuterol plus tiotropium inhalation, RV decrements ≥10 per cent as compared to baseline, in an individual subject, were considered as evidence of response to bronchodilators, according to O'Donnell et al. [Eur Respir J 2001; 18: 914-920]. They were calculated as follows: [RV, expressed in liters (L), before bronchodilators - RV (L) after bronchodilators/RV (L) after bronchodilators x 100]. (NCT01112241)
Timeframe: Baseline and 90 min after bronchodilators

Interventionper cent negative change (Mean)
Responsives to bronchodilators (n=8)Unresponsives to bronchodilators (n=9)
Albuterol Plus Tiotropium190

Reviews

7 reviews available for albuterol and Airway Obstruction

ArticleYear
Pediatric status asthmaticus.
    Critical care clinics, 2013, Volume: 29, Issue:2

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Airway Obstruction; Albuterol; Anti-Asthmatic A

2013
Inflammatory mediators in smoke inhalation injury.
    Inflammation & allergy drug targets, 2009, Volume: 8, Issue:1

    Topics: Adrenal Cortex Hormones; Airway Obstruction; Albuterol; Animals; Capillary Permeability; Heparin; Hu

2009
Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.
    Pulmonary pharmacology & therapeutics, 2003, Volume: 16, Issue:4

    Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Bronchodilator Agents; Dose-Response Relati

2003
Heliox during mechanical ventilation.
    Respiratory care, 2006, Volume: 51, Issue:6

    Topics: Aerosols; Airway Obstruction; Albuterol; Bronchodilator Agents; Helium; High-Frequency Ventilation;

2006
Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies.
    Respiratory care, 2000, Volume: 45, Issue:5

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aerosols; Airway Obstruction; Albuterol; Asthm

2000
Bronchodilation in mechanically ventilated patients: how much is enough and how best to deliver?
    Respiratory care, 2000, Volume: 45, Issue:7

    Topics: Administration, Inhalation; Aerosols; Airway Obstruction; Airway Resistance; Albuterol; Bronchoconst

2000
Inhibition of exercise-induced asthma by different pharmacological pathways.
    Thorax, 1976, Volume: 31, Issue:2

    Topics: Adolescent; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Bronchodilator Agents; Chil

1976

Trials

80 trials available for albuterol and Airway Obstruction

ArticleYear
Evaluation of inhaled salbutamol effectiveness under supportive use of electrical impedance tomography in ventilated ICU patients: study protocol for a randomised controlled clinical trial.
    BMJ open, 2019, 03-12, Volume: 9, Issue:3

    Topics: Administration, Inhalation; Airway Obstruction; Albuterol; Bronchodilator Agents; Chronic Disease; C

2019
Effect of salbutamol on the measurement of single-breath diffusing capacity.
    Respirology (Carlton, Vic.), 2013, Volume: 18, Issue:8

    Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Carbon Monoxide; Fema

2013
Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2014, Volume: 51, Issue:6

    Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Budesonide; Child;

2014
Comparison between the effects of generic and original salmeterol/fluticasone combination (SFC) treatment on airway inflammation in stable asthmatic patients.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2014, Volume: 97 Suppl 3

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Cross-

2014
Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults.
    The Journal of allergy and clinical immunology, 2015, Volume: 136, Issue:3

    Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Airway Obstruction; Albuterol; Anti-As

2015
Seretide withdrawal increases airway inflammation in moderate COPD patients.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:11

    Topics: Aged; Airway Obstruction; Albuterol; Androstadienes; Drug Combinations; Fluticasone-Salmeterol Drug

2009
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms.
    Respiratory medicine, 2010, Volume: 104, Issue:7

    Topics: Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method

2010
Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction.
    Equine veterinary journal, 2011, Volume: 43, Issue:4

    Topics: Administration, Inhalation; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents; Female; H

2011
Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma.
    European journal of clinical pharmacology, 2012, Volume: 68, Issue:10

    Topics: Administration, Inhalation; Adult; Airway Obstruction; Albuterol; Arteries; Asthma; Bronchoconstrict

2012
Association of airway pentosidine levels with bronchodilator response mediated by salbutamol administration in asthmatic patients.
    Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:6

    Topics: Adult; Airway Obstruction; Albuterol; Arginine; Asthma; Biomarkers; Bronchial Provocation Tests; Bro

2012
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate.
    The Journal of allergy and clinical immunology, 2003, Volume: 112, Issue:1

    Topics: Adult; Airway Obstruction; Albuterol; Androstadienes; Asthma; Biopsy; Bronchi; Cromolyn Sodium; Doub

2003
Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD.
    The European respiratory journal, 2003, Volume: 22, Issue:6

    Topics: Acetates; Administration, Inhalation; Administration, Oral; Aged; Airway Obstruction; Albuterol; Bro

2003
Pulmonary function in bronchopulmonary dysplasia.
    Pediatric pulmonology, 2004, Volume: 37, Issue:3

    Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Bronchopulmonary Dysplasia; Child, Preschool;

2004
Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation.
    Anesthesiology, 2004, Volume: 100, Issue:5

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Aged; Airway Obstruction; Albuterol; Analysis o

2004
Relevance of a portable spirometer for detection of small airways obstruction.
    Pediatric pulmonology, 2005, Volume: 39, Issue:2

    Topics: Administration, Inhalation; Adolescent; Airway Obstruction; Albuterol; Bronchodilator Agents; Child;

2005
Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma.
    Chest, 2005, Volume: 127, Issue:2

    Topics: Adolescent; Adult; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bronchodilator Agents;

2005
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Respirology (Carlton, Vic.), 2007, Volume: 12, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Aged; Airway Obstruction; Albuterol; Androstadienes; Anti-Asthmatic

2007
Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    British journal of diseases of the chest, 1980, Volume: 74, Issue:1

    Topics: Adolescent; Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Bronchodilator Agents; Clinical

1980
[Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].
    Wiener medizinische Wochenschrift (1946), 1980, Jun-15, Volume: 130, Issue:11

    Topics: Aerosols; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Drug Combinations; Ethanolami

1980
The immediate effect of sodium cromoglycate on the airway.
    Annals of allergy, 1982, Volume: 48, Issue:1

    Topics: Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Child; Cromolyn Sodium; Female; Humans

1982
A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
    European journal of respiratory diseases, 1980, Volume: 61, Issue:3

    Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Bronchitis; Chronic Disease; Clenbuterol; Clinical Tr

1980
A comparative trial of combination therapy in obstructive airways disease.
    Current medical research and opinion, 1980, Volume: 7, Issue:1

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Aminophylline; Delayed-Action Preparations; Drug Therapy

1980
The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy.
    Respiratory medicine, 1995, Volume: 89, Issue:4

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Carcinoma, Bronchogenic; Drug Com

1995
The reversibility of airway obstruction to an inhaled beta 2-adrenergic agent is less satisfactory after methacholine testing in asthmatic subjects.
    Chest, 1995, Volume: 107, Issue:5

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchial Provocation Tests; Double-Blind Method

1995
Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children.
    The Journal of allergy and clinical immunology, 1993, Volume: 91, Issue:1 Pt 1

    Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Ast

1993
Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
    Thorax, 1993, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Asthma; Chemistry, Pharmaceutical; Double-Bl

1993
The efficacy and safety of inhaled salmeterol 50 microg bd in older patients with reversible airflow obstruction.
    Age and ageing, 1996, Volume: 25, Issue:1

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Airway Obstruction; A

1996
Ineffectiveness of intravenous beta 2-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction.
    Respiration; international review of thoracic diseases, 1996, Volume: 63, Issue:1

    Topics: Adrenergic beta-Agonists; Aged; Airway Obstruction; Albuterol; Blood Gas Analysis; Chronic Disease;

1996
Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease.
    Annals of emergency medicine, 1997, Volume: 29, Issue:4

    Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volu

1997
Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.
    American journal of respiratory and critical care medicine, 1997, Volume: 156, Issue:4 Pt 1

    Topics: Administration, Inhalation; Adult; Airway Obstruction; Albuterol; Androstadienes; Anti-Asthmatic Age

1997
Early parenteral corticosteroid administration in acute asthma.
    The American journal of emergency medicine, 1997, Volume: 15, Issue:7

    Topics: Acute Disease; Adult; Aerosols; Airway Obstruction; Albuterol; Anti-Asthmatic Agents; Anti-Inflammat

1997
Reversible airway obstruction in rheumatic mitral valve disease.
    Respirology (Carlton, Vic.), 1998, Volume: 3, Issue:1

    Topics: Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volume; Human

1998
Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction.
    Allergy, 1998, Volume: 53, Issue:7

    Topics: Administration, Inhalation; Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross

1998
Assessing the reversibility of airway obstruction.
    Chest, 1998, Volume: 114, Issue:6

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Chronic Disease; Female; Humans;

1998
Equivalent bronchodilation with salbutamol given via pMDI or turbuhaler.
    American journal of respiratory and critical care medicine, 1999, Volume: 159, Issue:5 Pt 1

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross-Over Studies; Dose-Response

1999
Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.
    Thorax, 1999, Volume: 54, Issue:2

    Topics: Administration, Inhalation; Administration, Topical; Adolescent; Airway Obstruction; Albuterol; Anti

1999
Tolerance to beta-agonists during acute bronchoconstriction.
    The European respiratory journal, 1999, Volume: 14, Issue:2

    Topics: Acute Disease; Adolescent; Adrenergic beta-Agonists; Adult; Airway Obstruction; Albuterol; Asthma; B

1999
Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: double-blind, placebo-controlled crossover study in cystic fibrosis.
    Pediatric pulmonology, 2001, Volume: 31, Issue:6

    Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Airway Obstruction; Albuterol; Bronchodilat

2001
Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction.
    Journal of the American Veterinary Medical Association, 2001, Jun-15, Volume: 218, Issue:12

    Topics: Administration, Inhalation; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents; Cross-Ove

2001
Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.
    British journal of clinical pharmacology, 1977, Volume: 4, Issue:1

    Topics: Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Catechols; Forced Expir

1977
[Parasympathicolytic drugs in treatment of obstructive lung diseases (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1979, Aug-03, Volume: 104, Issue:31

    Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Cromolyn Sodi

1979
Cross-over study of the efficacy of four beta 2-sympathomimetic bronchodilator aerosols.
    British journal of clinical pharmacology, 1979, Volume: 8, Issue:1

    Topics: Adrenergic beta-Agonists; Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Analysis of Variance

1979
Letter: Alpha-receptor-blocking drugs in bronchial asthma.
    Lancet (London, England), 1975, Feb-08, Volume: 1, Issue:7902

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Airway Obstruction; Airway Resistance; Albut

1975
The bronchodilator effect of NAB 365.
    British journal of clinical pharmacology, 1977, Volume: 4, Issue:1

    Topics: Adult; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Clinical Trials as Topic; Ethan

1977
Indoramin--an alpha adrenoreceptor antagonist for airway obstruction.
    British journal of diseases of the chest, 1977, Volume: 71, Issue:2

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Clinical Trials as Topic; Drug Therapy, Combination; Fem

1977
Albuterol and ephedrine in patients with reversible obstructive airway disease.
    Annals of allergy, 1977, Volume: 38, Issue:6

    Topics: Airway Obstruction; Albuterol; Blood Pressure; Clinical Trials as Topic; Ephedrine; Forced Expirator

1977
Treatment of airways obstruction by continuous nebulization with and without assisted ventilation.
    Scandinavian journal of respiratory diseases. Supplementum, 1977, Volume: 101

    Topics: Aged; Airway Obstruction; Albuterol; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Inte

1977
Salbutamol by pressure-packed aerosol and by intermittent positive pressure ventilation in chronic obstructive bronchitis.
    British journal of diseases of the chest, 1978, Volume: 72, Issue:2

    Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Bronchitis; Chronic Disease; Clinical Trials as Topic

1978
A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction.
    Thorax, 1979, Volume: 34, Issue:1

    Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Clinical Trials as Topi

1979
A clinical trial of choline theophyllinate versus salbutamol with placebo control.
    The Journal of international medical research, 1979, Volume: 7, Issue:5

    Topics: Administration, Oral; Adult; Aged; Airway Obstruction; Albuterol; Bronchodilator Agents; Choline; Cl

1979
A comparative assessment of three bronchodilator preparations in general practice.
    The Journal of international medical research, 1979, Volume: 7 Suppl 1

    Topics: Airway Obstruction; Albuterol; Aminophylline; Delayed-Action Preparations; Humans; Peak Expiratory F

1979
A comparative crossover study of two long-acting bronchodilator preparations.
    Current medical research and opinion, 1976, Volume: 4, Issue:3

    Topics: Adult; Airway Obstruction; Albuterol; Aminophylline; Clinical Trials as Topic; Delayed-Action Prepar

1976
Comparison of salmefamol and salbutamol in patients with chronic airways obstruction.
    British journal of clinical pharmacology, 1976, Volume: 3, Issue:1

    Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Chronic Disease; Clinical Trials as Topic; Drug Ev

1976
Carbuterol: a double-blind clinical trial comparing carbuterol and salbutamol.
    Current therapeutic research, clinical and experimental, 1976, Volume: 19, Issue:2

    Topics: Adult; Airway Obstruction; Albuterol; Asthma; Blood Pressure; Bronchitis; Bronchodilator Agents; Cli

1976
Inhibition of exercise-induced asthma by different pharmacological pathways.
    Thorax, 1976, Volume: 31, Issue:2

    Topics: Adolescent; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Bronchodilator Agents; Chil

1976
Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.
    British medical journal, 1975, Feb-22, Volume: 1, Issue:5955

    Topics: Aerosols; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Atropine; Atropine Derivatives;

1975
Proceedings: Comparison of two bronchodilators--salmefamol and salbutamol.
    Tubercle, 1975, Volume: 56, Issue:2

    Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Clinical Trials as Topic; Ethanolamines; Human

1975
Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol.
    Current medical research and opinion, 1975, Volume: 3, Issue:1

    Topics: Adult; Aerosols; Airway Obstruction; Albuterol; Asthma; Blood Pressure; Bronchi; Bronchitis; Broncho

1975
A trial of oral delta-1-(trans)-tetrahydrocannabinol in reversible airways obstruction.
    Thorax, 1975, Volume: 30, Issue:1

    Topics: Administration, Oral; Adult; Aged; Airway Obstruction; Albuterol; Animals; Blood Pressure; Bronchodi

1975
Comparative assessment of a new breath-actuated inhaler in patients with reversible airways obstruction.
    Respiration; international review of thoracic diseases, 1992, Volume: 59, Issue:3

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Asthma; Double-Blind Method; Forced Expiratory Volume; H

1992
Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
    The American review of respiratory disease, 1992, Volume: 146, Issue:2

    Topics: Adult; Airway Obstruction; Albuterol; Analysis of Variance; Asthma; Double-Blind Method; Drug Therap

1992
Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma.
    The Journal of allergy and clinical immunology, 1992, Volume: 89, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bronchial

1992
Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
    Annals of allergy, 1992, Volume: 68, Issue:3

    Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Child; Dose-R

1992
Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.
    Thorax, 1992, Volume: 47, Issue:1

    Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Drug Administration Schedul

1992
The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
    Thorax, 1991, Volume: 46, Issue:1

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchoconstriction; Dose-Response Relationship,

1991
[Effects of ipratropium bromide and salbutamol on isolated lung hyperinflation in symptom-free intervals in asthmatic children].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1990, Volume: 138, Issue:3

    Topics: Administration, Inhalation; Adolescent; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives;

1990
[Inhalation bronchodilators in infancy--comparative study between salbutamol and ipratropium bromide].
    Pneumologie (Stuttgart, Germany), 1990, Volume: 44, Issue:5

    Topics: Airway Obstruction; Albuterol; Atropine Derivatives; Female; Humans; Infant; Infant, Newborn; Ipratr

1990
[The bronchodilator effect of aerosol beta-2-mimetic and anticholinergic agents in patients with chronic bronchitis].
    Revue des maladies respiratoires, 1990, Volume: 7, Issue:1

    Topics: Aerosols; Airway Obstruction; Albuterol; Bronchi; Bronchitis; Bronchodilator Agents; Chronic Disease

1990
The role of alpha and beta adrenoceptors in airway hyperresponsiveness to histamine.
    The Journal of allergy and clinical immunology, 1985, Volume: 75, Issue:3

    Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Airway Obstruction; Albutero

1985
[Beta-2 specificity of bronchially active sympathomimetics using capillary laser Doppler sonography exemplified by tulobuterol].
    Praxis und Klinik der Pneumologie, 1987, Volume: 41, Issue:4

    Topics: Adrenergic beta-Agonists; Adult; Airway Obstruction; Albuterol; Double-Blind Method; Female; Humans;

1987
A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action.
    Pharmatherapeutica, 1986, Volume: 4, Issue:7

    Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Atropine Derivatives; Blood Pressure; Dose-Response R

1986
A comparison of oral procaterol and albuterol in reversible airflow obstruction.
    The American review of respiratory disease, 1988, Volume: 138, Issue:6

    Topics: Administration, Oral; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Clinical Trials

1988
Bronchospasmolytic effects of salbutamol as powder inhalation in patients with reversible bronchial obstruction.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:10

    Topics: Adult; Airway Obstruction; Albuterol; Bronchitis; Clinical Trials as Topic; Double-Blind Method; Fem

1988
A comparison of albuterol and metaproterenol nebulizer solutions.
    Annals of allergy, 1987, Volume: 58, Issue:6

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Clinical Trials as Topic; Double-Blind Method; Humans; I

1987
Effects of the calcium antagonist tiapamil on pulmonary gas exchange in patients with chronic obstructive pulmonary disease who receive salbutamol.
    Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:1

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Double-Blind Method; Drug Evaluation; Drug Interactions;

1985
A clinical trial of long-term oral salbutamol in reversible diffuse airway obstruction.
    The American review of respiratory disease, 1973, Volume: 108, Issue:6

    Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchitis; Chronic Disease; Clinica

1973
Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.
    British medical journal, 1973, Oct-20, Volume: 4, Issue:5885

    Topics: Aged; Airway Obstruction; Albuterol; Atropine; Bronchitis; Bronchodilator Agents; Chronic Disease; C

1973
The role of oral bronchodilator therapy as shown by a comparison between salbutamol and terbutaline.
    Current medical research and opinion, 1973, Volume: 1, Issue:9

    Topics: Administration, Oral; Adult; Airway Obstruction; Albuterol; Asthma; Blood Pressure; Clinical Trials

1973
Comparison of cardiorespiratory effects of terbutaline and salbutamol aerosols in patients with reversible airways obstruction.
    Thorax, 1973, Volume: 28, Issue:5

    Topics: Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Cardiac Output; Clinical Trials as Topic; Hear

1973
A comparative trial of salbutamol and isoprenaline in asthma.
    Annals of clinical research, 1974, Volume: 6, Issue:2

    Topics: Adult; Aerosols; Airway Obstruction; Albuterol; Asthma; Carbon Dioxide; Female; Heart Rate; Humans;

1974

Other Studies

79 other studies available for albuterol and Airway Obstruction

ArticleYear
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
    Chest, 2018, Volume: 153, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent

2018
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
    Chest, 2018, Volume: 153, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent

2018
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
    Chest, 2018, Volume: 153, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent

2018
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
    Chest, 2018, Volume: 153, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent

2018
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
    Chest, 2018, Volume: 153, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent

2018
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
    Chest, 2018, Volume: 153, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent

2018
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
    Chest, 2018, Volume: 153, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent

2018
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
    Chest, 2018, Volume: 153, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent

2018
Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction.
    Chest, 2018, Volume: 153, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Asthma; Autopsy; Bronchodilator Agent

2018
Cross-sectional study of reversible airway obstruction in LAM: better evidence is needed for bronchodilator and inhaled steroid use.
    Thorax, 2019, Volume: 74, Issue:10

    Topics: Administration, Inhalation; Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross-Secti

2019
Bronchial obstruction and reversibility in children: inspiratory or expiratory resistance?
    The European respiratory journal, 2014, Volume: 44, Issue:1

    Topics: Airway Obstruction; Albuterol; Asthma; Bronchial Diseases; Bronchodilator Agents; Case-Control Studi

2014
The relationship between early reversibility test and maximal inspiratory pressure in patients with airway obstruction.
    International journal of chronic obstructive pulmonary disease, 2014, Volume: 9

    Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Albuterol; Bronchodilator Agents; Forced Expirat

2014
Airway obstruction, upper airway artifact and response to bronchodilator in asthmatic and healthy children.
    Pediatric pulmonology, 2015, Volume: 50, Issue:11

    Topics: Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; Child; Female; Huma

2015
Paramedic assessment and treatment of upper airway obstruction in pediatric patients: an exploratory analysis by the Children's Safety Initiative-Emergency Medical Services.
    The American journal of emergency medicine, 2016, Volume: 34, Issue:3

    Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Agonists; Airway Obstruction; Albu

2016
Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    International journal of chronic obstructive pulmonary disease, 2016, Volume: 11

    Topics: Administration, Inhalation; Aged; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Cros

2016
[Risk reduction by pharmaceutical intervention. Medication management using the example of salbutamol].
    Medizinische Monatsschrift fur Pharmazeuten, 2016, Volume: 39, Issue:1

    Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Child; Humans; Medication Therapy Management;

2016
The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma.
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Acute Disease; Administration, Inhalation; Airway Obstruction; Albuterol; Asthma; Double-Blind Metho

2016
Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma.
    Canadian respiratory journal, 2016, Volume: 2016

    Topics: Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Child; Child, Preschool; Female; Human

2016
[Salbutamol improves diaphragmatic contractility in chronic airway obstruction].
    Archivos de bronconeumologia, 2009, Volume: 45, Issue:5

    Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Alkalosis; Animals; Chronic Disease; Diaphr

2009
Effects of airway obstruction on albuterol-mediated variations in the resistive and elastic properties of the respiratory system of patients with asthma.
    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2009, Volume: 35, Issue:7

    Topics: Adolescent; Adult; Aged; Airway Obstruction; Airway Resistance; Albuterol; Analysis of Variance; Ast

2009
Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.
    COPD, 2010, Volume: 7, Issue:6

    Topics: Aged; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Female; Humans; Lung Volume Meas

2010
Bacterial tracheitis: a varied entity.
    Pediatric emergency care, 2011, Volume: 27, Issue:10

    Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Bronchoscopy; Child; Exudates and Transudates;

2011
Oral thermal injury associated with puncture of a salbutamol metered-dose inhaler in a dog.
    Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2012, Volume: 22, Issue:4

    Topics: Airway Obstruction; Albuterol; Animals; Burns; Dog Diseases; Dogs; Female; Metered Dose Inhalers; Mo

2012
Respiratory impedance response to a deep inhalation in asthmatic children with spontaneous airway obstruction.
    The European respiratory journal, 2002, Volume: 19, Issue:6

    Topics: Adolescent; Airway Obstruction; Airway Resistance; Albuterol; Analysis of Variance; Asthma; Bronchod

2002
Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness.
    Journal of investigational allergology & clinical immunology, 2002, Volume: 12, Issue:2

    Topics: Acetaldehyde; Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adult; Airway Obstruc

2002
Acute respiratory distress after upper airway obstruction following palatoplasty.
    International journal of pediatric otorhinolaryngology, 2003, Volume: 67, Issue:4

    Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Child; Diuretics; Furosemide; Humans; Male; Pa

2003
Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals.
    Pediatric pulmonology, 2003, Volume: 35, Issue:5

    Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Breath Tests; Bronchodilator Agents

2003
Three 20-minute interspaced salbutamol inhalations as a test for the diagnosis of reversible airflow limitation in adult asthmatics.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2004, Volume: 41, Issue:1

    Topics: Administration, Inhalation; Administration, Oral; Aged; Airway Obstruction; Albuterol; Anti-Inflamma

2004
Is bronchodilator response in 2-yr-old children associated with asthma risk factors?
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2004, Volume: 15, Issue:4

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Airway Obstruction; Albuterol; Bronchodilator A

2004
Images in clinical medicine. Airway dilatation after inhalation of a beta-agonist.
    The New England journal of medicine, 2005, Apr-14, Volume: 352, Issue:15

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Airway Obstruction; Albuterol; Asthma;

2005
Plethysmograph and interrupter resistance measurements in prematurely born young children.
    Archives of disease in childhood. Fetal and neonatal edition, 2006, Volume: 91, Issue:3

    Topics: Airway Obstruction; Airway Resistance; Albuterol; Bronchodilator Agents; Functional Residual Capacit

2006
[FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
    Pneumonologia i alergologia polska, 2005, Volume: 73, Issue:2

    Topics: Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Female; Follow-Up Studies

2005
Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction.
    The Journal of allergy and clinical immunology, 2006, Volume: 118, Issue:3

    Topics: Acetates; Adolescent; Airway Obstruction; Albuterol; Asthma; Child; Chronic Disease; Cyclopropanes;

2006
Preparedness of selected pediatric offices to respond to critical emergencies in children.
    Pediatric emergency care, 2006, Volume: 22, Issue:11

    Topics: Airway Obstruction; Albuterol; Anticonvulsants; California; Child; Child, Preschool; Data Collection

2006
Nebulised ipratropium bromide and salbutamol causing closed-angle glaucoma.
    Lancet (London, England), 1984, Sep-22, Volume: 2, Issue:8404

    Topics: Acute Disease; Aerosols; Aged; Airway Obstruction; Albuterol; Atropine Derivatives; Drug Therapy, Co

1984
The effect of vagolytic drugs on airway obstruction in patients with bronchial asthma.
    Annals of allergy, 1981, Volume: 46, Issue:6

    Topics: Airway Obstruction; Albuterol; Asthma; Atropine; Forced Expiratory Volume; Humans; Ipratropium; Maxi

1981
Safety and efficacy of salbutamol aerosol on Dermatophagoides farinae induced bronchospasm in asthmatic patients.
    Annals of allergy, 1984, Volume: 53, Issue:5

    Topics: Administration, Intranasal; Adolescent; Adult; Aerosols; Airway Obstruction; Albuterol; Antigens; As

1984
Corticosteroid resistance in chronic asthma.
    British medical journal (Clinical research ed.), 1981, May-02, Volume: 282, Issue:6274

    Topics: Adrenal Cortex Hormones; Adult; Airway Obstruction; Albuterol; Asthma; Bronchi; Chronic Disease; Cir

1981
MMEF or FEV1 in estimating bronchial obstruction in asthmatic children.
    Allergy, 1983, Volume: 38, Issue:3

    Topics: Administration, Intranasal; Adolescent; Airway Obstruction; Albuterol; Asthma; Bronchospirometry; Ch

1983
[Use of fiber bronchoscopy in emergency medicine].
    Der Internist, 1980, Volume: 21, Issue:1

    Topics: Airway Obstruction; Albuterol; Beclomethasone; Bronchoscopy; Emergencies; Female; Fiber Optic Techno

1980
[Significance of reversibility of obstructive respiratory disorders in bronchial asthma for prognosis of the effectiveness of treatment].
    Terapevticheskii arkhiv, 1980, Volume: 52, Issue:3

    Topics: Aerosols; Airway Obstruction; Albuterol; Asthma; Humans; Prognosis

1980
Reversible airway obstruction in cystic fibrosis.
    Thorax, 1980, Volume: 35, Issue:10

    Topics: Adolescent; Age Factors; Airway Obstruction; Albuterol; Asthma; Child; Child, Preschool; Cystic Fibr

1980
Effectiveness of nebulised salbutamol administered in ambulances to patients with severe acute asthma.
    Thorax, 1995, Volume: 50, Issue:1

    Topics: Acute Disease; Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Airway Obstru

1995
Exacerbation of airway hyperreactivity by (+/-)salbutamol in sensitized guinea pig.
    Japanese journal of pharmacology, 1993, Volume: 63, Issue:2

    Topics: Airway Obstruction; Albuterol; Animals; Bronchial Hyperreactivity; Guinea Pigs; Male; Ovalbumin; Res

1993
Bronchodilators in infancy.
    Thorax, 1993, Volume: 48, Issue:4

    Topics: Airway Obstruction; Albuterol; Child, Preschool; Humans; Infant; Infant, Newborn; Respiratory Sounds

1993
Pressure oscillations after flow interruption in relation to lung mechanics.
    Respiration physiology, 1995, Volume: 102, Issue:2-3

    Topics: Adolescent; Adult; Airway Obstruction; Airway Resistance; Albuterol; Carbachol; Child; Humans; Lung;

1995
Oscillatory pressure transients after flow interruption during bronchial challenge test in children.
    The European respiratory journal, 1997, Volume: 10, Issue:1

    Topics: Acoustics; Adolescent; Air; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bronchial Prov

1997
Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood.
    The Journal of allergy and clinical immunology, 1997, Volume: 99, Issue:5

    Topics: Adolescent; Adult; Affect; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Female; Hum

1997
Choking after inhaling a foreign body through a Ventolin puffer.
    The Medical journal of Australia, 1998, May-04, Volume: 168, Issue:9

    Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Foreign Bodies; Humans; Nebulizers and Vaporiz

1998
Language of dyspnea in assessment of patients with acute asthma treated with nebulized albuterol.
    American journal of respiratory and critical care medicine, 1998, Volume: 158, Issue:3

    Topics: Acute Disease; Administration, Inhalation; Adult; Airway Obstruction; Albuterol; Asthma; Bronchodila

1998
Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction.
    American journal of veterinary research, 1999, Volume: 60, Issue:6

    Topics: Administration, Inhalation; Aerosols; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents;

1999
Pulmonary distribution of aerosolized technetium Tc 99m pentetate after administration of a single dose of aerosolized albuterol sulfate in horses with recurrent airway obstruction.
    American journal of veterinary research, 1999, Volume: 60, Issue:6

    Topics: Administration, Inhalation; Aerosols; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents;

1999
Intraoperative breathing circuit obstruction caused by albuterol nebulization.
    Anesthesia and analgesia, 1999, Volume: 89, Issue:3

    Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Child; Epilepsy; Female; Humans; Hysterectomy;

1999
Short-acting beta2-agonists.
    Lancet (London, England), 2000, Sep-09, Volume: 356, Issue:9233

    Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Airway Obstruction; Albuterol; Asthma; Bro

2000
Exercise-induced asthma.
    British journal of diseases of the chest, 1975, Volume: 69, Issue:1

    Topics: Acidosis, Respiratory; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Airway Obstruction; Air

1975
[Induced beta-adrenergic stimulation and blockade in asthma bronchomotor effects (author's transl)].
    Respiration; international review of thoracic diseases, 1975, Volume: 32, Issue:4

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Airway Obstruction; Airway Resistance; Albute

1975
Effect of beta-adrenoreceptor stimulants on exercise-induced asthma.
    Pediatrics, 1975, Volume: 56, Issue:5 pt-2 sup

    Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Asthma; Child; Epinephrine; Humans; Isoetha

1975
[Broncholytic aerosols; with special attention to juvenile patients].
    Wiener medizinische Wochenschrift. Supplement, 1978, Volume: 51

    Topics: Adolescent; Aerosols; Age Factors; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Body He

1978
[Management of severe asthma in childhood (author's transl)].
    Monatsschrift fur Kinderheilkunde, 1977, Volume: 125, Issue:11

    Topics: Acetylcysteine; Age Factors; Airway Obstruction; Albuterol; Aminophylline; Asthma; Bromhexine; Child

1977
Reversibility of airways obstruction in bronchiectasis.
    Thorax, 1978, Volume: 33, Issue:5

    Topics: Adult; Airway Obstruction; Albuterol; Bronchiectasis; Female; Humans; Hypersensitivity; Male; Middle

1978
[Pathogenesis and prevention of exercise-induced asthma].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1978, Issue:84

    Topics: Airway Obstruction; Albuterol; Asthma; Humans; Physical Exertion

1978
Peripheral airways obstruction in patients with rhinitis.
    Annals of allergy, 1979, Volume: 42, Issue:1

    Topics: Adult; Airway Obstruction; Albuterol; Female; Forced Expiratory Volume; Humans; Male; Maximal Midexp

1979
[Clinical and functional aspects of obstructive respiratory syndromes following administration of a single dose of salbutamol in aerosol form].
    Minerva medica, 1977, Feb-18, Volume: 68, Issue:8

    Topics: Aerosols; Aged; Airway Obstruction; Albuterol; Chronic Disease; Female; Humans; Male; Maximal Expira

1977
Reversibility of small airway obstruction after therapy with salbutamol. Studies in asymptomatic asthmatic patients after inhalation of pressurized aerosol.
    Chest, 1977, Volume: 71, Issue:4

    Topics: Adolescent; Adult; Aerosols; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Female; Force

1977
Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
    The Medical journal of Australia, 1976, Apr-03, Volume: 1, Issue:14

    Topics: Adult; Airway Obstruction; Albuterol; Aminophylline; Chronic Disease; Female; Humans; Injections, In

1976
Nocturnal asthma and sudden death.
    American family physician, 1976, Volume: 14, Issue:6

    Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Circadian Rhythm; D

1976
[Epidemiological contribution to the etiology of chronic bronchitis. III. Standardization of methods suitable for the study of bronchial hyperreactivity and allergy in epidemiology].
    Revue de l'Institut d'hygiene des mines, 1976, Volume: 31, Issue:1

    Topics: Acetylcholine; Airway Obstruction; Albuterol; Bronchial Diseases; Bronchitis; Bronchodilator Agents;

1976
Relationship between spontaneous dyspnoea and lability of airway obstruction in asthma.
    Clinical science (London, England : 1979), 1992, Volume: 82, Issue:6

    Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Asthma; Bronchi; Carbachol; Dyspnea; Female;

1992
Albuterol.
    Neonatal network : NN, 1992, Volume: 11, Issue:7

    Topics: Airway Obstruction; Albuterol; Bronchi; Drug Administration Schedule; Humans; Infant

1992
[Study of circadian rhythm of bronchial patency for timely correction and evaluation of the effectiveness of inhalation powder forms of salbutamol in children with bronchial asthma].
    Pediatriia, 1992, Issue:4-6

    Topics: Administration, Inhalation; Adolescent; Airway Obstruction; Albuterol; Asthma; Bronchi; Child; Circa

1992
Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre.
    Thorax, 1991, Volume: 46, Issue:1

    Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volume; Humans; Ipra

1991
Bronchodilator and corticosteroid reversibility in ambulatory patients with airways obstruction.
    Danish medical bulletin, 1991, Volume: 38, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Dr

1991
Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage.
    European journal of pharmacology, 1991, Jan-25, Volume: 193, Issue:1

    Topics: Administration, Inhalation; Airway Obstruction; Airway Resistance; Albuterol; Animals; Bronchodilato

1991
Reversal of A23187-induced airway constriction in the guinea pig.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 248, Issue:3

    Topics: Airway Obstruction; Airway Resistance; Albuterol; Animals; Calcimycin; Dose-Response Relationship, D

1989
The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs.
    The American review of respiratory disease, 1988, Volume: 138, Issue:5

    Topics: Airway Obstruction; Airway Resistance; Albuterol; Allergens; Animals; Asthma; Bronchi; Bronchoalveol

1988
Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics.
    Pediatric pulmonology, 1988, Volume: 4, Issue:4

    Topics: Adolescent; Adult; Airway Obstruction; Albuterol; Child; Cystic Fibrosis; Drug Therapy, Combination;

1988
The perception of asthma.
    Australian paediatric journal, 1986, Volume: 22, Issue:1

    Topics: Adolescent; Airway Obstruction; Albuterol; Asthma; Child; Female; Forced Expiratory Volume; Humans;

1986
Can thoracic gas volume be measured in infants with airways obstruction?
    The American review of respiratory disease, 1986, Volume: 133, Issue:2

    Topics: Airway Obstruction; Airway Resistance; Albuterol; Bronchiolitis, Viral; Cystic Fibrosis; Functional

1986
Measurement of reversibility of airways obstruction: which parameters to use?
    Respiration; international review of thoracic diseases, 1985, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Aged; Airway Obstruction; Albuterol; Child; Female; Forced Expiratory Volume; Hum

1985
Bronchial asthma.
    The Practitioner, 1974, Volume: 212, Issue:1269

    Topics: Adrenocorticotropic Hormone; Aerosols; Airway Obstruction; Albuterol; Aminophylline; Antigens; Asthm

1974
Changes in specific airways conductance and forced expiratory volume in one second after a bronchodilator in normal subjects and patients with airways obstruction.
    Thorax, 1974, Volume: 29, Issue:5

    Topics: Administration, Oral; Adult; Aerosols; Airway Obstruction; Airway Resistance; Albuterol; Asthma; Bro

1974
[Treatment of bronchiolar obstruction].
    Minerva medica, 1974, Dec-19, Volume: 65, Issue:91

    Topics: Aerosols; Airway Obstruction; Albuterol; Asthma; Bronchial Diseases; Bronchial Spasm; Diagnosis, Dif

1974
A comparison of Berotec (Th1165a) and Salbutamol aerosols.
    The New Zealand medical journal, 1973, Sep-12, Volume: 78, Issue:498

    Topics: Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Blood Pressure; Bronchodilator Agents; Female;

1973
Closing volume, spirometry and nitrogen wash-out in provoked asthma treated with salbutamol.
    Scandinavian journal of respiratory diseases. Supplementum, 1974, Volume: 85

    Topics: Adolescent; Adult; Airway Obstruction; Airway Resistance; Albuterol; Allergens; Asthma; Female; Huma

1974
Effect of salbutamol on the peripheral circulation in man.
    Chest, 1973, Volume: 64, Issue:4

    Topics: Adolescent; Adult; Aerosols; Aged; Airway Obstruction; Albuterol; Blood Circulation; Blood Pressure;

1973
Management of severe viral bronchiolitis and severe acute asthma.
    Archives of disease in childhood, 1974, Volume: 49, Issue:2

    Topics: Acute Disease; Airway Obstruction; Albuterol; Aminophylline; Anti-Bacterial Agents; Asthma; Bronchio

1974
An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction. With special reference to a beta-2 stimulant--salmefamol.
    Thorax, 1974, Volume: 29, Issue:3

    Topics: Adult; Aerosols; Airway Obstruction; Albuterol; Analysis of Variance; Bronchodilator Agents; Ethanol

1974